• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ADPT

ADPT

Adaptive Biotechnologies Corporation

NASDAQHealthcareBiotechnologyUS

USD15.99

+0.85 (+5.61%)

Rating:D+

Company Profile

CEO

Chad Robins

IPO Date

2019-06-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$15.04

Prev. Close

$15.14

Day Low

$14.76

Day High

$16.00

52W Low

$9.78

52W High

$20.76

Market Cap

$2.56B

Volume

2.24M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

17.1%

Avg Negative

9.1%

Avg Neutral

73.8%

News Feed

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021

GlobeNewsWire·7/12/2021·↓ negative

This Explosive Biotech Is Taking On a Huge New Market

The Motley Fool·6/30/2021·↑ positive

New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

GlobeNewsWire
·6/9/2021
·↑ positive

Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

GlobeNewsWire·5/20/2021·↑ positive

Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

Adaptive Biotechnologies Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/5/2021·↑ positive

Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference

GlobeNewsWire·4/27/2021·↑ positive

GenomeWeb Index Drops 3% for 2nd Consecutive Month

GuruFocus·4/13/2021·↓ negative

We're really excited that these genomics companies, says Ark's Simon Barnett

CNBC Television·4/12/2021·↑ positive